Guoke Ion Makes Its Debut at AOCMP 2026, Domestic Ion Therapy Technology Draws Attention from Asia-Pacific Peers

During the congress, the Guoke Ion team conducted technical presentations and exchanges through specialized seminars and a corporate exhibition booth. At the specialized seminar, the team systematically introduced the company's ion therapy equipment and its self-developed PHOENIX Plan treatment planning system, with a focus on sharing the industry development status, clinical application achievements, and cutting-edge research progress in China's heavy ion therapy field, clearly demonstrating to international experts the R&D and implementation of domestic ion medical technology.

At the exhibition site, the Guoke Ion booth attracted experts in the field of medical physics from home and abroad to stop and exchange. The team engaged in in-depth face-to-face communication with industry experts, and the related technical products and innovative research achievements received high attention and recognition from the industry. Through the diverse format of "specialized presentations + on-site engagement," this congress effectively expanded the company's international industry network and built a high-quality bridge for subsequent cross-border technical exchanges, academic discussions, and industrial cooperation.
This participation in AOCMP 2026 is an important measure for Guoke Ion to advance its internationalization layout. Leveraging the Asia-Pacific academic exchange platform, the company successfully showcased to the international industry the exploration and breakthroughs of domestic ion therapy technology, enhancing professional mutual trust between Chinese and foreign medical physics fields. In the future, Guoke Ion will continue to deepen its work in ion medical care, strengthen international exchange and cooperation, accelerate the international promotion of domestic high-end medical technology, and enhance the international influence of China's ion medical industry.
Disclaimer: Information republished from partner media, institutions or other websites is provided for reference and communication purposes only. It does not imply endorsement of its views or verification of its accuracy. Please contact us if any content infringes rights or requires correction.